Akoya Biosciences 

$1.29
11
-$0.1-7.19% Monday 20:00

Statistics

Day High
1.29
Day Low
1.29
52W High
3.42
52W Low
0.93
Volume
704,629
Avg. Volume
568,899
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

11AugExpected
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.48
-0.37
-0.27
-0.16
Expected EPS
-0.204617
Actual EPS
N/A

Financials

-67.79%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
81.67MRevenue
-55.37MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AKYA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bionano Genomics
BNGO
Mkt Cap17.42M
Bionano Genomics offers genomic analysis solutions, competing with Akoya in the broader genomics and cell analysis market.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health operates in the precision oncology market, offering liquid biopsy tests that compete with Akoya's tissue-based imaging for cancer diagnosis.
Illumina
ILMN
Mkt Cap18.99B
Illumina provides sequencing and array-based solutions for genetic analysis, indirectly competing with Akoya's imaging technologies in the genomics research space.
Pacific Biosciences of California
PACB
Mkt Cap702.87M
Pacific Biosciences offers long-read sequencing technologies, competing in the broader genomics market where Akoya operates with its imaging solutions.
Intellia Therapeutics
NTLA
Mkt Cap1.35B
Intellia Therapeutics is involved in CRISPR gene editing, a technology used in genomic research where Akoya's imaging solutions can also be applied.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals, through its focus on genetic sequencing and analysis for drug development, competes indirectly with Akoya's imaging technologies in research applications.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers a wide range of laboratory equipment and consumables, including imaging systems that compete with Akoya's products.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation, through its life sciences segment, offers various analytical instruments and consumables that compete with Akoya's imaging solutions.
Agenus
AGEN
Mkt Cap126.5M
Agenus Inc. focuses on immuno-oncology, a field where Akoya's multiplex imaging can be applied, making them indirect competitors in the research and diagnostic markets.

About

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers Proxima, a cloud-based platform to store, analyze, and share spatial data; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
Show more...
CEO
Mr. Brian McKelligon
Employees
205
Country
US
ISIN
US00974H1041

Listings

0 Comments

Share your thoughts

FAQ

What is Akoya Biosciences stock price today?
The current price of AKYA is $1.29 USD — it has decreased by -7.19% in the past 24 hours. Watch Akoya Biosciences stock price performance more closely on the chart.
What is Akoya Biosciences stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Akoya Biosciences stocks are traded under the ticker AKYA.
Is Akoya Biosciences stock price growing?
AKYA stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Akoya Biosciences has showed a +5.74% increase.
What is Akoya Biosciences revenue for the last year?
Akoya Biosciences revenue for the last year amounts to 81.67M USD.
What is Akoya Biosciences net income for the last year?
AKYA net income for the last year is -55.37M USD.
How many employees does Akoya Biosciences have?
As of April 03, 2026, the company has 205 employees.
In which sector is Akoya Biosciences located?
Akoya Biosciences operates in the Health Care sector.
When did Akoya Biosciences complete a stock split?
Akoya Biosciences has not had any recent stock splits.
Where is Akoya Biosciences headquartered?
Akoya Biosciences is headquartered in Marlborough, US.